National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
These findings highlight the detrimental impact of payor barriers to treatment for children with IBD. Reforms that minimize delays in care and provider administrative burden are imperative to ensure that children receive timely evidence-based treatment that improves disease outcomes and prevents adverse events.
Authors
- Jennifer L. Dotson (ORCID: https://orcid.org/0000-0001-6193-3179)
- Jonathan Moses (ORCID: https://orcid.org/0000-0002-6660-4494)
- Lucia Mirea (ORCID: https://orcid.org/0000-0001-6724-2213)
- Sandra Kim (ORCID: https://orcid.org/0000-0002-7028-2563)
- Brad D. Constant (ORCID: https://orcid.org/0000-0002-9447-4885)
- Andrew Ritchey (ORCID: https://orcid.org/0000-0002-0735-1407)
- Jeremy Adler (ORCID: https://orcid.org/0000-0003-1741-7876)
- Jenifer R. Lightdale (ORCID: https://orcid.org/0000-0003-1268-0181)
- Frank I. Scott (ORCID: https://orcid.org/0000-0002-6021-0419)
- Edwin F. de Zoeten (ORCID: https://orcid.org/0000-0002-0946-9759)
- Shehzad Saeed
- Brad Pasternak (ORCID: https://orcid.org/0000-0003-1912-871X)
- Benjamin D. Gold
Institutions
- Boston Children's Hospital (US)
- Arkansas Children's Hospital (US)
- Cleveland Clinic (US)
- Wright State University (US)
- University of Michigan (US)
- Children's Hospital Colorado (US)
- GI Care for Kids (US)
- Dayton Children's Hospital (US)
- Phoenix Children's Hospital (US)
- Children's Center (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Arkansas for Medical Sciences (US)
- University of Colorado Denver (US)
- Stanford University (US)
Publication Details
- Journal
- JPGN Reports
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1002/jpr3.70004
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82